Innovative new insulin delivery device provides better convenience for pet owners while enhancing treatment compliance

MSD Animal Health has introduced Caninsulin VetPen, the first insulin pen specifically designed for diabetic dogs and cats.

VetPen features innovative technology that simplifies dosing and administration of insulin to make it easy for clients to accept and comply with their pets’ treatment.

Find out more about Caninsulin.

MSD Animal Health presents results of a vaccine against Schmallenberg virus to protect sheep and cattle

MSD Animal Health announces the successful development of a candidate vaccine against the Schmallenberg virus. Immediately after the first cases appeared at the end of 2011, MSD Animal Health started the emergency development program.

The vaccine is based on wild-type Schmallenberg virus that has been inactivated and contains an adjuvant that stimulates the immune response. In the studies to date, safety and efficacy has been demonstrated in calves, lambs and pregnant ewes.

“During the trials, all vaccinated animals were protected against Schmallenberg virus infection (complete blockage of viremia), whereas all controls developed viremia after challenge”, said Veronique Moulin, research scientist at the virological R&D department at MSD Animal Health.

More information on Schmallenberg.

NOBIVAC Myxo-RHD shows positive results in MSD Animal Health studies

The vaccine was proven to prevent infection of myxomatosis and rabbit hemorrhagic disease (RHD), and demonstrated no adverse side effects. The vaccine strain did not disseminate and was only found in the lymph node and skim immediately around the vaccination site.

Full details, diagnosis and spread of both myxomatosis and RHD can be found on Vetstream.

Recent surveys show despite the prevalance of rabbits as pets in Europe few owners have them vaccinated. If owners visit the practice for advice, ensure they know the importance of vaccinating their rabbits just as they would a dog or cat.

PORCILIS M Hyo ID ONCE receives approval from EU

The new mycoplasma hyopneumoniae vaccine is available as a single shot and can be administrated intradermally. This is a marked improvement on previous vaccines which required two shots and required intramuscular administration.

Learn more about mycoplasma hyopneumoniae and the dangers it presents on Vetstream.

For a full breakdown of the new vaccine visit MSD Animal Health

Richard Deluca, formerly of BD Biosciences and Wyeth has been made president of Merck’s Animal Health (MSD) division.

Merck provide a diverse range of products you may use such as Caninsulin and Influenza vaccines, and recently acquired Intervet and Schering-Plough.

Deluca praised the work of his predecessor Raul Kohan in making Merck a worldwide success, who retires on September 15.

For more information on Merck please click here.